Enrollment, profit fall at ITT Educational
The Carmel-based operator of for-profit colleges earned $85.4 million in the three months ended March 31, a 2.4-percent decline from the same quarter a year ago.
Public Companies
Articles
Analysts demand news on next Lilly blockbuster
Eli Lilly and Co. spends a lot of time these days telling the rest of the story—how well it’s doing in areas not connected to highly lucrative drugs about to see their patents expire. But for the most part, investors and analysts just want to know when the next blockbuster will be coming.
Charges drive down first-quarter profit at Lilly
First-quarter profit fell at Eli Lilly and Co. as the company recorded restructuring charges due to its downsizing and higher research costs as it tries to develop new drugs to help it shrug off its looming patent expirations.
Software firm seeks to reorganize as holding company
Interactive Intelligence Inc. will ask shareholders at its next annual meeting to vote on a proposal to reorganize the software firm under a new holding company called Interactive Intelligence Group Inc.
Zimmer goes on offensive against lawyers
The Warsaw-based maker of orthopedic implants has filed suit to stop a Detroit-area law firm from making allegedly false claims and using its trademarks on websites designed to attract plaintiffs to sue Zimmer over one of its knee-replacement implants called NexGen.
Remy International files plans for public offering
Pendleton-based manufacturer Remy International Inc., the former General Motors Co. unit that exited bankruptcy in 2007, has filed plans to raise up to $100 million through an initial public stock offering.
Another suit filed in Emmis, financier dispute
Emmis Communications Corp. is accusing Alden Global Capital, which once backed Emmis CEO Jeff Smulyan’s attempt to take the company private, of violating the “short-swing rule.” This is the third suit involving the parties since Smulyan called off the move last year.
Finish Line reports rise in quarterly earnings, sales
The Indianapolis-based retailer earned $34.3 million in its fiscal quarter, compared with $30.6 million a year ago. Revenue rose 2.7 percent, to $384.6 million.
Toning-shoe trend fading, but doesn’t trip up Finish Line
The toning trend in athletic shoes apparently has run its course. Sales of the oddly shaped shoes fell more than 45 percent in the fourth quarter for The Finish Line Inc., but the local retailer still posted improved profit and revenue.
Drugmakers call off animal-health deal, possible asset sale
Drugmakers Merck & Co. and Sanofi-Aventis SA have abandoned plans to combine their animal-health businesses after wrestling with regulators for a year over potential divestitures.
Indianapolis-based Eli Lilly and Co. was among a list of possible suitors for about $1 billion in assets the two companies considered selling.
Allison Transmission files for $750M IPO
Allison Transmission Inc. is counting on upgrades to truck and bus fleets in countries like China and India for its future growth, the company revealed in a filing it made Friday to raise up to $750 million through an initial public offering.
Shoe Carnival reports record annual profit
The Evansville-based shoe and apparel retailer said it earned $26.8 million in its last fiscal year. The company also reported record same-store sales.
PROXY CORNER: Eli Lilly and Co.
Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 (www.lilly.com) discovers, develops, manufactures and sells pharmaceutical products for humans and animals.
Annual profit, revenue shrink for Noble Roman’s
The Indianapolis-based pizza franchisor saw declining results from its restaurants, but got a boost from its growing line of take-and-bake products.
Lechleiter: After the deluge, we’ll be fine
Eli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly will be just fine after it has sustained the damage of the next three years.
Lilly agrees to buy European animal health company
Elanco, the animal health division of Eli Lilly and Co., has agreed to acquire Jannsen Animal Health, a subsidiary of New Jersey-based Johnson & Johnson, pending regulatory approval. Financial terms of the deal were not disclosed.
Noble Roman’s expands grocery offerings to boost bottom line
The Indianapolis company, founded in 1972, started as a chain of sit-down family restaurants but continues to find new outlets for its products.
Hurco turns first quarterly profit in two years
The Indianapolis-based machine tool maker reported profit of $1.5 million on revenue of $39.7 million in its fiscal first quarter.
New federal rules prompt ITT to change bonus-pay criteria
The Carmel-based for-profit educator still will pay its top executives bonuses, but they’ll no longer be tied to school enrollment, the company said Tuesday in a proxy filing.
Indiana executives pare stock holdings
Executives and directors at several Indiana public companies took advantage of market strength in February to pare back their stock holdings, narrowly missing a pullback sparked by turmoil in Libya.